Chemistry:DODC

From HandWiki
Revision as of 07:17, 8 February 2024 by BotanyGa (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
DODC
DODC structure.png
Identifiers
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC11H15Cl2NO2
Molar mass264.15 g·mol−1
3D model (JSmol)

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-Dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020,[1] though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

See also

References

  1. Kruegel AC, "Phenalkylamines and Methods of Treating Mood Disorders.", WO patent 2022/006186, published January 2022, assigned to Gilgamesh Pharmaceuticals.